3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
16
Stomach Neoplasms
13
Lung Neoplasms
9
Adenocarcinoma
5
Neoplasms
4
Neoplasm Metastasis
4
Esophageal Neoplasms
4
Adenocarcinoma Of Esophagus
3
Squamous Cell Carcinoma of Head and Neck
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Urinary Bladder Neoplasms
1
Thymoma
1
Solid Tumors
1
Solid Cancer
1
Sarcoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Metastatic Small Intestinal Adenocarcinoma
1
Metastatic Gastric Adenocarcinoma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Digestive System Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Clinical Stage IVB Gastric Cancer AJCC v8
1
Interventions
Gemcitabine
15
Cisplatin
15
pembrolizumab
9
Oxaliplatin
7
durvalumab
5
Leucovorin
5
Fluorouracil
5
130-nm albumin-bound paclitaxel
5
Platinum
4
Albumin-Bound Paclitaxel
4
1,2-diaminocyclohexaneplatinum II citrate
4
Trastuzumab
3
Taxes
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Capecitabine
3
zanidatamab
2
fludarabine
2
Paclitaxel
2
Nivolumab
2
Folfox protocol
2
Docetaxel
2
Cyclophosphamide
2
Biopsy
2
tucatinib
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
tivozanib
1
pertuzumab
1
peposertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Ramucirumab
×
1 year
×
Clear all
No trials found.